Journal of Pharmacokinetics & Experimental Therapeutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Pharmacokinet Exp Ther 2023, Vol 7(5): 5
  • DOI: 10.4172/jpet.1000201

Understanding Multidrug Resistant Microorganisms in Intensive Care Units to Combat Resistance

Shuli Teng*
Department of Medicine, Zhejiang, China
*Corresponding Author : Shuli Teng, Department of Medicine, Zhejiang, China, Email: shuliteng@zjsru.edu.cn

Received Date: Oct 30, 2023 / Published Date: Oct 31, 2023

Abstract

Multidrug-resistant microorganisms have become a pressing concern within the intensive care units (ICUs) of healthcare facilities worldwide. This article delves into the multifaceted problem of antimicrobial resistance in ICUs, where patients are most vulnerable, and explores strategies to mitigate this growing healthcare challenge. Drawing upon recent research and clinical experiences, the gravity of the situation is illuminated, emphasizing the importance of multifaceted interventions to combat the rise of multidrug resistance. This article underscores the need for a coordinated approach involving antibiotic stewardship, infection prevention, research and development, and public awareness to safeguard patient well-being and the future of intensive care.

Citation: Teng S (2023) Understanding Multidrug Resistant Microorganisms inIntensive Care Units to Combat Resistance. J Pharmacokinet Exp Ther 7: 201. Doi: 10.4172/jpet.1000201

Copyright: © 2023 Teng S. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top